Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Alberts

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Nuclear Medicine Communications|January 22, 2021
The influence of colour scale in lesion detection and patient-based sensitivity in [68Ga]Ga-PSMA-PET/CTClemens Mingels, Christos Sachpekidis, Karl P Bohn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2023
[<sup>177</sup>Lu]Lu-PSMA-617 Therapy in a Patient with Chronic Kidney DiseaseLorenzo Mercolli, Clemens Mingels, Giulia Manzini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2019
The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and gangliaIan Alberts, Christos Sachpekidis, Lotte Dijkstra, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2022
Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer's diseaseJiehui Jiang, Min Wang, Ian Alberts, et al.
Journal of Alzheimer'S Disease : JAD|January 28, 2020
Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission TomographyLeonie Beyer, Matthias Brendel, Franziska Scheiwein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2021
Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CTIan Alberts, Jan-Niklas Hünermund, George Prenosil, et al.
Frontiers in Immunology|April 17, 2023
Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicityRaheem F H Al Aameri, Entkhab M A Alanisi, Adu Oluwatosin, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
Dual PET Imaging with [<sup>68</sup>Ga]Ga-DOTA-TOC and [<sup>18</sup>F]FDG to Localize Neuroendocrine Tumors of Unknown OriginAli Zaidi, Pavithraa Ravi, Ingrid Bloise, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2021
Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer UptakeIan Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2022
Abbreviated scan protocols to capture <sup>18</sup>F-FDG kinetics for long axial FOV PET scannersVarsha Viswanath, Hasan Sari, Austin R Pantel, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Nuclear Medicine Communications|January 22, 2021
The influence of colour scale in lesion detection and patient-based sensitivity in [68Ga]Ga-PSMA-PET/CTClemens Mingels, Christos Sachpekidis, Karl P Bohn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2023
[<sup>177</sup>Lu]Lu-PSMA-617 Therapy in a Patient with Chronic Kidney DiseaseLorenzo Mercolli, Clemens Mingels, Giulia Manzini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2019
The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and gangliaIan Alberts, Christos Sachpekidis, Lotte Dijkstra, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2022
Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer's diseaseJiehui Jiang, Min Wang, Ian Alberts, et al.
Journal of Alzheimer'S Disease : JAD|January 28, 2020
Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission TomographyLeonie Beyer, Matthias Brendel, Franziska Scheiwein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2021
Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CTIan Alberts, Jan-Niklas Hünermund, George Prenosil, et al.
Frontiers in Immunology|April 17, 2023
Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicityRaheem F H Al Aameri, Entkhab M A Alanisi, Adu Oluwatosin, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
Dual PET Imaging with [<sup>68</sup>Ga]Ga-DOTA-TOC and [<sup>18</sup>F]FDG to Localize Neuroendocrine Tumors of Unknown OriginAli Zaidi, Pavithraa Ravi, Ingrid Bloise, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2021
Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer UptakeIan Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2022
Abbreviated scan protocols to capture <sup>18</sup>F-FDG kinetics for long axial FOV PET scannersVarsha Viswanath, Hasan Sari, Austin R Pantel, et al.
Pageof 10